Non-GMO, high-protein ‘smart peas’ slated for 2021 debut, with other ‘super trait’ crop varieties to follow

GG June Cover image
Image: Greenhouse Grower

Equinom, an Israeli startup, raised $10 million in a Series B round of funding from BASF Venture Capital, Roquette, Trendlines Group and Fortissimo Capital. The company focuses on non-GMO seed breeding technology to make “smarter seeds.”

Founded in 2012, Equinom focuses on non-GMO seed varieties that have super traits, such as better nutritional profiles. “Equinom’s breeding program designs super-trait seeds on demand. The system determines the varieties and breeding generations needed to obtain the plant seeds defined by food companies. Equinom then breeds the plants naturally and conducts global growing trials to confirm seed viability in multiple cultivation locations,” Equinom said.

The company works with the natural genetic variation among plants to create seeds that are more nutritious and that have higher oil and protein content. Equinom shares that it is already a preferred supplier of sesame seeds. “We also plan to launch our high-protein pea variety in 2021 ….” Gil Shalev, CEO of Equinom, said.

Equinom’s technology optimizes non-GMO seeds to create higher yields, more nutritional value and resistance to disease. The company uses a combination of traditional crossbreeding and computational genetic algorithms to accomplish this. It has also accelerated seed breeding for faster production.

Read the original post

{{ reviewsTotal }}{{ options.labels.singularReviewCountLabel }}
{{ reviewsTotal }}{{ options.labels.pluralReviewCountLabel }}
{{ options.labels.noReviewsLabel }}
{{ options.labels.newReviewButton }}
{{ userData.canReview.message }}

Related Articles

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Does glyphosate—the world's most heavily-used herbicide—pose serious harm to humans? Is it carcinogenic? Those issues are of both legal and ...

Most Popular

ChatGPT-Image-Jul-10-2026-12_21_03-PM
Viewpoint: Is there new evidence that the animal deworming drug ivermectin decreases the risk of Covid and cancer? Don’t waste your money.
leeteam
How Kennedy and his family could pocket millions from Merck’s $50 million vaccine injury settlement that he oversaw
Screenshot-2026-07-30-at-3.07.42-PM
Controversy over WNBA star Sophie Cunningham’s comment opposing trans females in women’s sports reinvigorates the culture wars
Screenshot-2026-07-09-at-1.09.25-PM
Anti-vaccine myths rattle health care
Screenshot-2026-07-30-at-2.30.35-PM
Climate scientists claim conservative activists are promoting ‘lies’ that Europe’s summer heatwaves are far from unusual
ChatGPT-Image-Mar-10-2026-01_39_01-PM
Viewpoint—“Miracle molecule” debunked: Why acemannan supplements don’t work
Picture1
Hiroshima at 81: America’s new nuclear bomb, a buried Iranian target, and a question no one wants to ask
ChatGPT Image Jul 29, 2026, 05_50_04 PM
Fear, science, and the law: If talc powder is unlikely to cause cancer and J&J was winning in court, why did it pay more than $5.5 billion to settle?
ChatGPT Image Jul 29, 2026, 12_05_21 PM
AI-generated physicians promoting bogus cures and worthless supplements surge on social media
ChatGPT Image Jul 29, 2026, 10_14_27 PM
After muzzling RFK, Jr. over autism-vaccine conspiracy theories, Trump defies aides to push scares again
ChatGPT Image Jul 29, 2026, 06_26_01 PM 2
Facts & Fallacies podcast: Organic food myths make a comeback on Instagram, with Dr. Kevin Folta
Screenshot 2026-07-22 at 1.38
Viewpoint: Are the U.S. and Europe headed towards a repudiation of agricultural biotechnology red tape?

Sorry. No data so far.

glp menu logo outlined

Get news on human & agricultural genetics and biotechnology delivered to your inbox.